# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Florence Nightingale (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI004-SYN-TD
- Date: 1858-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Isobel Marchetti, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

New patient visit for nearly three years of exhausting fatigue that worsens after exertion. **S**

## Historical basis

- Florence Nightingale was born on May 12, 1820, in Florence, Italy, where her parents were on a European tour; her elder sister, Frances Parthenope, was born in 1819. **D**
- In October 1854 she led a party of thirty-eight nurses from London to the British military hospitals at Scutari, arriving in November 1854. **D**
- In May 1855, a few days after crossing to Balaclava to inspect the hospitals in the Crimea, she fell ill with what the army doctors called Crimean fever. She was carried to the Castle Hospital, was dangerously ill and, by her own later account, very near to death; she was reported out of danger on May 24 and made a slow and painful recovery before returning to work at Scutari. **D**
- Modern writers have interpreted her Crimean fever as brucellosis and her long later illness as chronic brucellosis. **R**
- She returned to England in the summer of 1856, emaciated and tense, and pressed for a royal commission on the health of the army, which was established in 1857. **D**
- In 1857, while working on her report for the commission, she was overworking and in failing health; she sought rest at Malvern in August and September and again in December, but would not stop working. She collapsed with cardiac symptoms so severe that it was thought she would die, and afterward suffered from nausea, insomnia, and palpitations. On her doctors' orders she took to her bed or couch but continued to work, the beginning of about twenty years of invalidism. **D**
- Her own 830-page report, Notes on Matters Affecting the Health, Efficiency, and Hospital Administration of the British Army (1858), used statistical evidence to show how much army mortality was due to conditions in the hospitals. She was elected to the Statistical Society, the first woman member. **D**
- Her prolonged illness has also been read retrospectively as what is now called myalgic encephalomyelitis/chronic fatigue syndrome, while other writers have proposed neurasthenia, a psychosomatic illness, or illness used to secure time for work. **R**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Nearly three years of exhausting fatigue since a severe febrile illness on an overseas deployment, with crashes lasting days after any push of work. **S**
- Lightheaded with a racing heart when standing in a line or at the stove. **S**
- Wants above all to keep doing her statistical and policy work, even if much of it has to be done from her sofa or bed. **S**

## Strengths and supports

- Supports: a small team of trusted colleagues who visit her at home to work, and a wide network of correspondents **S**

## Medications and allergies

- Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- May 1855: Crimean fever at Balaclava: dangerously ill and near death, then a slow and painful recovery; she called it typhus **D** (CLM-0003)
- May 1855: Retrospective interpretation of the Crimean fever as brucellosis, without laboratory confirmation (possible, not established) **R** (CLM-0004)
- August 1857: Overwork and failing health during the army health commission, with rest at Malvern, a collapse with cardiac symptoms, then nausea, insomnia, and palpitations; took to her bed or couch on doctors' orders but kept working **D** (CLM-0006)

## Procedures and immunizations

- 1858-03-02 to 1858-03-02: Ten-minute passive standing test (NASA lean test): heart rate 66/min supine and 92/min at 10 minutes (rise of 26/min); blood pressure 106/68 supine and 102/70 standing; lightheadedness and leg mottling from minute 6; no orthostatic hypotension and below the 30/min threshold for postural tachycardia syndrome **S**
- 1842-09-20: Hepatitis B vaccine, adult three-dose series completed **S**
- 1853-09-13: Tdap vaccine **S**
- 1857-10-20: Influenza vaccine, 1857-1858 season **S**

## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Hemoglobin: 12.9 g/dL; White cell count: 5.8 10*3/uL; Platelets: 246 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; Glucose: 86 mg/dL; Calcium: 9.3 mg/dL; Albumin: 4.3 g/dL; ALT: 16 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.6 mg/dL; Phosphate: 3.6 mg/dL; ESR: 8 mm/h; CRP: 1.2 mg/L; TSH: 1.9 mIU/L; HbA1c: 5.1%; Ferritin: 48 ng/mL; Tissue transglutaminase IgA: 1 U/mL; Creatine kinase: 92 U/L; Morning cortisol: 14.2 ug/dL; Vitamin B12: 410 pg/mL; Folate: 12.4 ng/mL; 25-hydroxyvitamin D: 17 ng/mL (low); PHQ-9: 8; GAD-7: 5; PROMIS fatigue T-score: 71; PROMIS physical function T-score: 32; Pain score (0 to 10): 4. All results are synthetic.

BP 104/66 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 55 kg; BMI 19 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, precise, and articulate; tires visibly toward the end of a long conversation and loses words at times; Mood frustrated by her limits but not depressed; no hopelessness; PHQ-9 score 8 drawn mainly from the fatigue, sleep, and concentration items, with item 9 scored 0. Functional status: Moderate ME/CFS at intake: independent in self-care but housebound most days, walks about 10 minutes before symptoms worsen, and needs a rest after showering; works about three hours a day, reclined, in short blocks; By the six-month review: fewer crashes, out of the house twice a week, and working four to five hours a day in planned blocks with rest between. Physical examination is intentionally limited. **S**

## Assessment

1. Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS; status draft. **S**
2. Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse; status draft. **S**

## Plan

- Diagnose ME/CFS by clinical criteria after exclusion tests, explain that it is a real illness with no diagnostic test, and give her a written care and support plan, including a flare plan. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Energy management led by the patient: an activity and symptom diary, planned rest before and between tasks, work broken into short blocks, and heart-rate awareness; no graded exercise therapy or fixed increases in activity. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Infectious diseases consultation to look for relapsed or focal brucellosis or another persisting infection before attributing her symptoms to ME/CFS. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Clinical Overview of Brucellosis (2024); Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352(22):2325-2336 (2005) **S**
- Orthostatic intolerance measures: 2 to 2.5 L of fluid a day, more salt with meals, waist-high compression garments, and tasks done seated or reclined; repeat the standing test at six months. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Sleep, pain, and cognitive symptom care: a regular sleep window with rest periods kept short, acetaminophen as needed, no sedatives or opioids, and memory aids for work. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Review the care plan at every visit, with PHQ-9, PROMIS fatigue and physical function scores, and a pain score; primary care review at least yearly and more often while the plan is new. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021) **S**
- Workplace adjustments: home working, a reclined workstation, flexible hours, and meetings by video or at her home. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**

## Guideline basis

- Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021), National Institute for Health and Care Excellence
- Diagnosing ME/CFS (2024), Centers for Disease Control and Prevention
- Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023), Mayo Clinic Proceedings
- Clinical Overview of Brucellosis (2024), Centers for Disease Control and Prevention
- Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352(22):2325-2336 (2005), New England Journal of Medicine
